API Reddit Mentions | ChartExchange

>Regulation
First Products Registered in Ukraine by Curaleaf Ahead of Medical Cannabis Rollout
Ukraine has officially issued its first ever permit for medical cannabis to be imported into the country, bringing patients one step closer to receiving treatment.
>It represents the latest development in Ukraine’s nascent but rapidly evolving medical cannabis programme, after the country officially enshrined it into law last August...
>On June 02, 2025, Ukraine’s State Medical Service issued the first permit for the right to import medical cannabis substances into the country...
>As previously reported, on January 09, 2025, the first products were added to Ukraine’s State Register of Medicinal Products, a process which is required for all API’s coming into the country.
>These included three full-spectrum oils from Curaleaf, two balanced oils with either 10mg/ml or 25mg/ml of THC and CBD, and one with just 25mg/ml of THC.
>Given that it remains the only company to see products registered to date, it’s clear that Curaleaf’s products will be the first to be imported to the country. This has also been verified by local sources...
>“However, it should be understood that this is a complex and multi-level procedure. The regulatory framework, although largely formed, is still incomplete for the full implementation of medical cannabis.
>“In particular, CMU Resolution No. 589 provides for the annual approval of quotas by the Cabinet of Ministers, without which neither import nor cultivation of cannabis is possible. In 2024, the relevant import quotas have not yet been approved, which is the key reason for the delay. There is also uncertainty about the procedure for issuing master forms in pharmacies and the lack of a clear mechanism for including new items in the register of authorised drugs.”
>Part of this complication is the fact that Ukraine will be using a magistral system, meaning pharmacies will be required to produce these preparations in-house.
>Each Pharmacy will need to acquire licences for retail trade, manufacturing of medicines and trafficking in narcotic substances, limiting the number capable of handling medical cannabis to around 200.
>Furthermore, as we reported in January, despite significant interest from international cannabis businesses, many companies are struggling to get their products registered due to the strict and unique standards demanded by Ukrainian authorities.
>These strict regulations stem from Ukraine’s active pharmaceutical ingredient (API) registration process, which is uniform across all APIs regardless of their nature and is not a necessary step in countries like Germany or the UK...
>“So far, patients have not had time to feel real changes, as the implementation process is still ongoing. But we are glad that Ukraine has finally joined the civilized world, where access to treatment is a right, not a privilege… For millions of people, it is an opportunity to get rid of chronic pain, nausea, seizures and other severe manifestations of diseases that significantly impair their quality of life.”
>However, despite the post-war prevalence of Post Traumatic Stress Disorder (PTSD) among Ukrainians being a driving force behind legalisation, for now the condition will not be on the list for which medical cannabis can be prescribed...

.dark-mode .mVqtf0{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .mVqtf0{ color: #333333; background-color: white; border: 2px solid #333333; }APIAgora, Inc.stock NASDAQ ADR

API
Agora, Inc.
stock NASDAQ ADR